Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients.

Sternberg Z, Leung C, Sternberg D, Li F, Karmon Y, Chadha K, Levy E.

CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):104-11.

PMID:
23244431
2.

Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis.

Sternberg Z, Leung C, Sternberg D, Yu J, Hojnacki D.

Cardiovasc Ther. 2014 Apr;32(2):33-9. doi: 10.1111/1755-5922.12049.

PMID:
24119301
3.

Twenty-year trends in cardiovascular risk factors in India and influence of educational status.

Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC.

Eur J Prev Cardiol. 2012 Dec;19(6):1258-71. doi: 10.1177/1741826711424567. Epub 2011 Sep 26.

PMID:
21947630
4.

Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.

Muntoni S, Atzori L, Mereu R, Manca A, Satta G, Gentilini A, Bianco P, Baule A, Baule GM, Muntoni S.

Eur J Intern Med. 2009 Jul;20(4):373-7. doi: 10.1016/j.ejim.2008.10.007. Epub 2008 Dec 21.

PMID:
19524177
5.
6.

Vascular comorbidities in the onset and progression of multiple sclerosis.

Tettey P, Simpson S Jr, Taylor BV, van der Mei IA.

J Neurol Sci. 2014 Dec 15;347(1-2):23-33. doi: 10.1016/j.jns.2014.10.020. Epub 2014 Oct 16. Review.

PMID:
25454639
7.

Cardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: a cross-sectional comparative study.

Halvorsen S, Vøllestad NK, Provan SA, Semb AG, van der Heijde D, Hagen KB, Dagfinrud H.

Arthritis Care Res (Hoboken). 2013 Jun;65(6):969-76. doi: 10.1002/acr.21926.

8.

Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.

Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC; Hygia Project Investigators.

Chronobiol Int. 2013 Mar;30(1-2):116-31. doi: 10.3109/07420528.2012.702587. Epub 2012 Oct 25.

PMID:
23181613
9.

Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.

Vrethem M, Mattsson E, Hebelka H, Leerbeck K, Osterberg A, Landtblom AM, Balla B, Nilsson H, Hultgren M, Brattström L, Kågedal B.

Mult Scler. 2003 Jun;9(3):239-45.

PMID:
12814169
10.

Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.

Weinstock-Guttman B, Zivadinov R, Ramanathan M.

J Neurol Sci. 2011 Dec 15;311(1-2):86-91. doi: 10.1016/j.jns.2011.07.024. Epub 2011 Aug 16.

PMID:
21849177
12.

New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging.

Palavra F, Marado D, Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, Nunes CC, Gonçalves G, Teixeira F, Reis F.

Dis Markers. 2013;34(5):341-8. doi: 10.3233/DMA-130979.

13.

Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese.

Yang X, Sun K, Zhang W, Wu H, Zhang H, Hui R.

J Vasc Surg. 2007 Aug;46(2):296-302. Epub 2007 Jun 28.

14.
15.

Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.

Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R.

J Hum Hypertens. 2007 Oct;21(10):802-7. Epub 2007 May 31.

PMID:
17541383
16.

[The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].

Reindel J, Zander E, Heinke P, Kohnert KD, Allwardt C, Kerner W.

Herz. 2004 Aug;29(5):463-9. German.

PMID:
15340731
17.

Serum uric acid and multiple sclerosis.

Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D.

Clin Neurol Neurosurg. 2006 Sep;108(6):527-31. Epub 2005 Oct 3.

PMID:
16202511
18.

Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.

Tocci G, Ferrucci A, Passerini J, Averna M, Bellotti P, Bruno G, Cosentino F, Crepaldi G, Giannattasio C, Modena MG, Nati G, Tiengo A, Trimarco B, Vanuzzo D, Volpe M.

High Blood Press Cardiovasc Prev. 2011 Jun 1;18(2):43-51. doi: 10.2165/11593420-000000000-00000.

PMID:
21806078
19.
20.

Serum homocysteine levels in relation to clinical progression in multiple sclerosis.

Teunissen CE, Killestein J, Kragt JJ, Polman CH, Dijkstra CD, Blom HJ.

J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1349-53. doi: 10.1136/jnnp.2008.151555. Epub 2008 Aug 1.

PMID:
18676406
Items per page

Supplemental Content

Write to the Help Desk